AAASPS


Also found in: Acronyms.
African-American Antiplatelet Stroke Prevention Study. A clinical trial sponsored by the National Stroke Association, designed to assess stroke prevention, comparing the effectiveness of aspirin to Ticlid®—ticlopidine—in preventing recurrent stroke in African-American patients
Conclusion Aspirin is more effective

AAASPS

Cardiology A clinical trial–African-American antiplatelet stroke prevention study–sponsored by the National Stroke Association, designed to assess stroke prevention treatment; specifically, the study compares the effectiveness of aspirin to Hoffmann-La Roche's Ticlid®–ticlopidine in preventing recurrent stroke in African-American Pts
Mentioned in ?
References in periodicals archive ?
Nationwide, AAASPS recruited 1,809 adults who had experienced a noncardioembolic, ischemic stroke between 7 and 90 days before inclusion in the study.
But the two drugs performed differently in the real-life, high-risk population enrolled in AAASPS. At entry, 85% of the AAASPS subjects had hypertension, 42% had diabetes, 42% had hypercholesterolemia, 47% had a family history of stroke, 67% were current or past smokers, and 67% reported getting no leisure time exercise.
Researchers attending the conference called AAASPS historic and unique.